Walmart buys Israeli product review insight firm Aspectiva

Indonesia Berita Berita

Walmart buys Israeli product review insight firm Aspectiva
Indonesia Berita Terbaru,Indonesia Berita utama
  • 📰 Reuters
  • ⏱ Reading Time:
  • 49 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 23%
  • Publisher: 97%

Walmart said on Tuesday it has acquired Aspectiva, an Israeli start-up whose tec...

FILE PHOTO: Shoppers walk from a Walmart store in Mexico City, August 15, 2012. REUTERS/Edgard Garrido

TEL AVIV - Walmart said on Tuesday it has acquired Aspectiva, an Israeli start-up whose technology analyses consumers’ product reviews to help shoppers make decisions.Aspectiva will join Walmart’s Store No 8, the incubation arm launched by the U.S. retailer in 2017 to find new commerce-related technologies.

Aspectiva has developed machine-learning techniques and natural language processing capabilities, “areas we believe will have profound impact on how customers will shop in the future,” Store No 8 principal Lori Flees said. Walmart also has a strategic investment in Team8, an Israeli cybersecurity start-up incubator, and launched a joint venture with Eko, an interactive media and technology company with offices in Tel Aviv and New York.

Aspectiva was founded in 2013 and has raised $4 million, led by Jerusalem Venture Partners. Other investors include Japanese venture capital firm Global Brain, Finnish retailer Union Five and LivePerson.

Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

Reuters /  🏆 2. in US

Indonesia Berita Terbaru, Indonesia Berita utama

Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.

Why buying Walmart stock over Amazon is a better bet nowOld-school retailer Walmart has several advantages over its fast-moving rival Amazon.com, writes Jeff Reeves.
Baca lebih lajut »

Pharma giant Roche just bought biotech firm Spark, the maker of an $850,000 eye drugPharma giant Roche just bought biotech firm Spark, the maker of an $850,000 eye drugRoche is set to buy gene therapy firm Spark Therapeutics for about $4.8 billion. Spark's stock more than doubled in premarket trading.
Baca lebih lajut »

Fed minutes; Glencore caps coal; Setback for WalmartFed minutes; Glencore caps coal; Setback for WalmartHere's what you need to know about the markets before you start your business day.
Baca lebih lajut »



Render Time: 2025-03-26 21:56:32